3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
3
Lymphoma, T-Cell
2
Myelodysplastic Syndromes
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Interventions
pegaspargase
4
Oxaliplatin
3
Gemcitabine
3
Methotrexate
2
Etoposide
2
Early Intervention, Educational
2
Doxorubicin
2
Dexamethasone
2
sugemalimab
1
ferrous sulfate
1
ferric gluconate
1
Vincristine
1
Thalidomide
1
Sucrose
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Prednisone
1
Pharmacogenomic Testing
1
Ketamine
1
Drug Therapy
1
Darbepoetin alfa
1
Cyclophosphamide
1
Ciprofloxacin
1
Asian ginseng
1
Amoxicillin-Potassium Clavulanate Combination
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma, Extranodal NK-T-Cell
×
Alemtuzumab
×
Clear all
NCT00725231
2012-05-07
A-CHOP-14
University of Göttingen
Phase 3
Unknown
274 enrolled